Hengkang Medical Group Co Ltd (002219) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hengkang Medical Group Co Ltd (002219) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.35 Million ≈ $1.37 Million USD) by net assets (CN¥2.02 Billion ≈ $296.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hengkang Medical Group Co Ltd (002219) market capitalisation for the company's overall valuation and market capitalisation.
Hengkang Medical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Hengkang Medical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hengkang Medical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hengkang Medical Group Co Ltd ranked by their cash flow conversion efficiency. Explore Hengkang Medical Group Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZEAL Network SE
XETRA:TIMA
|
0.163x |
|
Shanghai STEP Electric Corp
SHE:002527
|
0.009x |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275
|
0.036x |
|
Burke & Herbert Financial Services Corp. Common Stock
NASDAQ:BHRB
|
0.046x |
|
Wenzhou Hongfeng Electrical Alloy Co Ltd
SHE:300283
|
0.047x |
|
Enovis Corp
NYSE:ENOV
|
0.051x |
|
Altareit
PA:AREIT
|
0.051x |
|
Helix Energy Solutions Group Inc
NYSE:HLX
|
0.015x |
Annual Cash Flow Conversion Efficiency for Hengkang Medical Group Co Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of Hengkang Medical Group Co Ltd from 2004 to 2024. View Hengkang Medical Group Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.04 Billion ≈ $298.62 Million |
CN¥438.51 Million ≈ $64.17 Million |
0.215x | +65.01% |
| 2023-12-31 | CN¥2.23 Billion ≈ $326.98 Million |
CN¥290.98 Million ≈ $42.58 Million |
0.130x | -14.23% |
| 2022-12-31 | CN¥1.77 Billion ≈ $258.33 Million |
CN¥268.04 Million ≈ $39.22 Million |
0.152x | -13.16% |
| 2021-12-31 | CN¥1.59 Billion ≈ $232.09 Million |
CN¥277.29 Million ≈ $40.58 Million |
0.175x | -90.28% |
| 2020-12-31 | CN¥157.84 Million ≈ $23.10 Million |
CN¥283.80 Million ≈ $41.53 Million |
1.798x | -32.10% |
| 2019-12-31 | CN¥207.51 Million ≈ $30.37 Million |
CN¥549.51 Million ≈ $80.41 Million |
2.648x | +1348.10% |
| 2018-12-31 | CN¥2.86 Billion ≈ $418.16 Million |
CN¥522.57 Million ≈ $76.47 Million |
0.183x | +488.16% |
| 2017-12-31 | CN¥4.35 Billion ≈ $636.19 Million |
CN¥-204.82 Million ≈ $-29.97 Million |
-0.047x | +71.81% |
| 2016-12-31 | CN¥4.17 Billion ≈ $610.59 Million |
CN¥-697.37 Million ≈ $-102.05 Million |
-0.167x | -390.19% |
| 2015-12-31 | CN¥3.80 Billion ≈ $556.49 Million |
CN¥219.02 Million ≈ $32.05 Million |
0.058x | -68.57% |
| 2014-12-31 | CN¥1.06 Billion ≈ $154.43 Million |
CN¥193.35 Million ≈ $28.29 Million |
0.183x | -5.06% |
| 2013-12-31 | CN¥820.80 Million ≈ $120.11 Million |
CN¥158.40 Million ≈ $23.18 Million |
0.193x | +30.82% |
| 2012-12-31 | CN¥560.65 Million ≈ $82.04 Million |
CN¥82.71 Million ≈ $12.10 Million |
0.148x | -25.75% |
| 2011-12-31 | CN¥477.16 Million ≈ $69.82 Million |
CN¥94.80 Million ≈ $13.87 Million |
0.199x | +27.73% |
| 2010-12-31 | CN¥414.18 Million ≈ $60.61 Million |
CN¥64.43 Million ≈ $9.43 Million |
0.156x | +69.04% |
| 2009-12-31 | CN¥354.57 Million ≈ $51.88 Million |
CN¥32.63 Million ≈ $4.77 Million |
0.092x | +28.34% |
| 2008-12-31 | CN¥311.99 Million ≈ $45.65 Million |
CN¥22.37 Million ≈ $3.27 Million |
0.072x | -67.90% |
| 2007-12-31 | CN¥142.72 Million ≈ $20.88 Million |
CN¥31.88 Million ≈ $4.67 Million |
0.223x | +79.57% |
| 2006-12-31 | CN¥108.93 Million ≈ $15.94 Million |
CN¥13.55 Million ≈ $1.98 Million |
0.124x | -69.47% |
| 2005-12-31 | CN¥89.67 Million ≈ $13.12 Million |
CN¥36.54 Million ≈ $5.35 Million |
0.407x | +38339.94% |
| 2004-12-31 | CN¥72.09 Million ≈ $10.55 Million |
CN¥76.41K ≈ $11.18K |
0.001x | -- |
About Hengkang Medical Group Co Ltd
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more